News Europe Maltese Medical Cannabis To Boost Exports

Maltese Medical Cannabis To Boost Exports



GCI Cannabis Leaders' Virtual Summit

THE Maltese approach to cannabis is set to see its total value of exports increase by 30%.

Malta decriminalised cannabis in 2013, and legalised medical cannabis in March, 2018 and has since made significant strides in becoming a leading player in the emerging European market.

In an interview with Health Europa in 2019 Marion Zammit of Malta Enterprise confirmed over 20 projects had been approved.

She said these included Canadian, Australian and US companies. In June, last year Aphria’s Malta subsidiary, ASG Pharma, received an import license from The Malta Medicines Authority.

Malta Enterprise has granted Canadian firm Aurora approval for a seed-to-pharma operation in partnership with local firm Cherubino.

Australian firm MGC Pharmaceuticals signed a deal with the Maltese government which will see it create an € 11m medical cannabis manufacturing plant.

Whilst Toronto firms MPXI and Supreme and US firm Columbia Care, are also amongst the 20 approved projects. 

Ms Zammit went on to say that once all approved projects are in operational it ‘will supplement exports by an additional 30%’, adding: “We are creating a new sub-niche in the manufacturing sector and this in turn will make our economy more robust.”

Malta, a small Mediterranean island with a population of less than half a million, has a strong advanced manufacturing and pharmaceutical base.

It promotes itself as being in an ‘ideal geographic location capable of  bridging continents’, with English being the language of choice for business. 

MGC Pharmaceuticals founder and director Nativ Segev said its move allows it to be a ‘part of Malta’s drive to become a beacon in Europe for the growth and development of this industry’. 

Economy Minister Chris Cardona said that as the first country in the EU to provide a regulatory framework for medical cannabis ‘it has been able to attract the best investment to our country, with the sector already contributing to economic growth’.

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.


Please enter your comment!
Please enter your name here

Latest news

Amazon Listing Boosts Sales For UK CBD Firm By ‘150%’

UK company fourfivecbd has seen a 150% sales increase of its muscle rub CBD balm following its...

European Commission Apologises Over Misleading Novel Food Statements – As Crucial Dates For Europe’s Cannabis Future Revealed

THE European Commission says it has stopped all non-synthetic Novel Food CBD applications - and apologised for...

Markets: World’s Leading Drug Companies Finding A Way Into Cannabis.

THE emerging cannabis industry is moving up the agenda for the pharmaceutical industry with two significant deals...

Amazon’s UK Launch Expected Within Weeks After Successful CBD Pilot Project

AMAZON’S CBD pilot is proving a success and set to debut in the UK later this year...


Meet The Two Cannabis Scientists Focused On Boosting Women’s Health

A PAIR of female scientists are leading the way when it comes to exploring the benefits CBD...

New UK Cannabis Fund Closes In On Its First $75m Investment

ONE of the UK’s first cannabis investment funds is being backed by two of the industry’s global...

Must read


You might also likeRELATED
Recommended to you